Will CVS Caremark add at least one other GLP-1 medication for weight…

Market overview

CVS Caremark is restoring coverage for Zepbound. This question explores whether they will expand their formulary to include other GLP-1 drugs for weight loss, indicating a broader shift in coverage strategy. The resolution will be based on publicly available formulary updates from CVS Caremark.

Economics prediction market

Implied probability (Yes)

60%

Closes

2029-08-26

More Economics markets

• OPEC partnership or acquisition announced? — 32% Yes
• Will Logistics Automation stock price increase by November 2026? — 59% Yes
• Grammy Awards partnership or acquisition announced? — 58% Yes
• Will IPO Market stock price increase by September 2026? — 46% Yes
• Will Interest Rates stock price increase by April 2027? — 41% Yes
• Chainsaw Man partnership or acquisition announced? — 74% Yes
• Fusion Energy partnership or acquisition announced? — 55% Yes
• Will Doja Cat stock price increase by November 2026? — 66% Yes

Browse all Economics markets →